Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 3, Mars 2003
Page(s) 327 - 336
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2003193327
Publié en ligne 15 mars 2003
  1. Demoly P, Messaad D, Benahmed S, et al. Les réactions immunoallergiques d’origine médicamenteuse: données épidémiologiques et cliniques. Therapie 2000; 55: 13–21.
  2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients. A meta-analysis of prospective studies. JAMA 1998; 279: 1200–5.
  3. Imb JL, Pouyanne P, Haramburu F, et al. Iatrogénie médicamenteuse: estimation de sa prévalence dans les hôpitaux publics français. Therapie 1999; 54: 21–7.
  4. Bigby M, Jick S, Jock H, Arndt K. Drug-induced cutaneous reactions. A report from the Boston collaborative drug surveillance program on 15,438 consecutive inpatients, 1975 to 1982. JAMA 1986; 256: 3358–63.
  5. Smith JW, Johnson JEIII, Cliff LE. Studies on the epidemiology of adverse drug reactions. II. An evaluation of penicillin allergy. N Engl J Med 1966; 274: 998–1002.
  6. Ibia EO, Schwartz RH, Wiedermann BL. Antibiotic rashes in children. Arch Dermatol 2000; 136: 849–54.
  7. Burke P, Burne SR. Allergy associated with ciprofloxacin. Br Med J 2000; 320: 679.
  8. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990; 175: 621–8.
  9. Laxenaire MC. Épidémiologie des réactions anaphylactoides peranesthésiques. Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999; 18: 796–809.
  10. Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994; 331: 1272–85.
  11. Lenler-Petersen P, Hansen D, Andersen M, et al. Drugrelated fatal anaphylactic shock in Denmark 1968- 1990. A study based on notifications to the Committee on Adverse Drug Reactions. J Clin Epidemiol 1995; 48: 1185–8.
  12. Sheikh A, Alves B. Hospital admissions for acute anaphylaxis: time trend study. Br Med J 2000; 320: 1441.
  13. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet 1991; 337: 1308–10.
  14. Lafaye P, Lapresles C. Fixation of penicilloyl groups to albumin and appearance of antipenicilloyl antibodies in penicillin-treated patients. J Clin Invest 1988; 82: 7–12
  15. Haddi E, Charpin D, Tafforeau M, et al. Atopy and systemic reactions to drugs. Allergy 1990; 45: 236–9.
  16. Romano A, De Santis A, Romito A, et al. Delayed hypersensitivity to aminopenicillins is related to major histocompatibility complex genes. Ann Allergy Asthma Immunol 1998; 80: 433–7.
  17. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M. Association of pyrazolone drug hypersensitivity with HLA-DQ and DR antigens. Clin Exp Allergy 1998; 28: 1353–8.
  18. Vittorio CC, Muglia JJ. Anticonvulsiviant hypersensitivity syndrome. Arch Intern Med 1995; 155: 2285–90.
  19. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670–4.
  20. Asero R. Detection of patients with multiple drug allergy syndrome by elective tolerance tests. Ann Allergy Asthma Immunol 1998; 80: 185–8.
  21. Khoury L, Warrington R. The multiple drug allergy syndrome: a matchedcontrol retrospective study in patients allergic to penicillin. J Allergy Clin Immunol 1996; 98: 462–4.
  22. Zanni MP, von Greyerz S, Scnyder B, Wendland T, Pichler WJ. HLA-restricted, processing- and metabolism independent pathway of drug recognition by human αβ T lymphocytes. J Clin Invest 1998; 102: 1591–8.
  23. Rieder MJ, Uetrcht J, Shear NH, Cannon M, Miller M, Spielberg SP. Diagnosis of sulfonamide hypersensitivity reactions by in vitro rechallenge with hydroxylamine metabolites. Ann Intern Med 1989; 110: 286–9.
  24. Shear NH, Spielberg SP, Grant DM, Tang BK, Kalow W. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity. Ann Intern Med 1986; 105: 179–84.
  25. Carr A, Gross AS, Hoskins JM, Penny R, Cooper DA. Acetylation phenotype and cutaneous hypersensitivity to trimethoprimsulphamethoxazole in HIVinfected patients. AIDS 1994; 8: 333–7.
  26. Wolkenstein P, Carriere V, Charue D, et al. A slow acetylator genotype is a risk factor for sulfonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndrome. Pharmacogenetics 1995; 5: 255–8.
  27. Naisbitt DJ, Vilar J, Stalford A, et al. Plasma cysteine and decreased reduction of nitroso sulphamethoxazole with HIV infection. AIDS Res Hum Retrovir 2000; 16: 1929–38.
  28. Buhl R, Jaffe HA, Holroyd KJ, et al. Systemic glutathion deficiency in symptom free HIVseropositive individuals. Lancet 1989; 334: 1294–8.
  29. Roujeau JC. Toxidermies médicamenteuses: quelques nouveautés. Rev Fr Allergol Immunol Clin 2002; 42: 71–4.
  30. Schnyder B, Mauri-Hellweg D, Zanni M, Bettens F, Pichler WJ. Direct, MHCdependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones. J Clin Invest 1997; 100: 136–41.
  31. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995; 155: 462–72.
  32. Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ. HLAunrestricted presentation of lidocaine by HLA-DR molecules to specific αβ+ T cell clones. Immunol Int 1998; 10: 507–15.
  33. Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in druginduced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433–41.
  34. Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine specific T cells. J Immunol 1997; 158: 1139–48.
  35. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490–3.
  36. Hari Y, Frutig-Schnyder K, Hurni M, et al. T cell involvement in cutaneous drug eruptions. Clin Exp Allergy 2001; 31: 1198–408.
  37. Blanca M, Posadas SJ, Torres MJ, et al. Expression of the skin-homing receptor in peripheral blood lymphocytes from subjects with nonimmediate cutaneous drug reactions. Allergy 2000; 55: 998–1004.
  38. Posadas SJ, Leyva L, Torres MJ, et al. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reactions. J Allergy Clin Imunol 2000; 106: 769–76.
  39. Weltzien HU, Padovan E. Molecular features of penicillin allergy. J Invest Dermatol 1998; 110: 203–6.
  40. Barbaud A, Béné MC, Reichert-Penetrat S, Jacquin-Petit MA, Schmutz JL, Faure GC. Immunocompetent cells and adhesion molecules in 14 cases of cutaneous drug reactions induced with the use of antibiotics. Arch Dermatol 1998; 134: 1040–1.
  41. Hertl M, Bohlen H, Jugert F, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by β-lactam antibiotics. J Invest Dermatol 1993; 101: 794–9.
  42. Reilly TP, Lash LH, Doll MA, et al. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions. J Invest Dermatol 2000; 114: 1164–73.
  43. Demoly P, Kropf R, Bircher A, Pichler WJ. Drug hypersensitivity questionnaire. Allergy 1999; 54: 999–1003.
  44. Brochow K, Romano A, Blanca M, Ring J, Pichler WJ, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2003 (sous presse).
  45. Barbaud A. Gonçalo M, Bruynzeel D, Bircher A. Guidelines for skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis 2001; 45: 321–8.
  46. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputabilité des effets inattendus ou toxiques des médicaments. Actualisation de la méthode utilisée en France. Therapie 1985; 40: 111–4.
  47. Guilloux L, Ricard-Blum S, Ville G, Motin J. Histamine release assay and radioimmunoassay for the detection of IgE antibodies against neuromuscular blocking drugs. Ann Fr Anesth Reanim 1993; 12: 182–6.
  48. Lebel B, Messaad D, Kvedariene V, Rongier M, Bousquet J, Demoly P. Cysteinyl-leukotriene release test (CAST) in the diagnosis of immediate drug reactions. Allergy 2001; 56: 688–92.
  49. Nyfeler B, Pichler WJ. The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity. Clin Exp Allergy 1997; 27: 175–81.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.